Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

Cancer, Pulmonary Specialists Join UC San Diego Department of Pediatrics

 

November 20, 2009  |  

Two new physician-researchers have joined the UC San Diego School of Medicine’s Department of Pediatrics. Donald L. Durden, MD, PhD, has been named professor and Vice Chair for Research in the Department of Pediatrics and Research Director, Division of Hematology/Oncology at the Moores UCSD Cancer Center. James S. Hagood, MD, will serve as the new Chief of the Division of Pulmonary Medicine in the Department of Pediatrics.

Durden will help build the basic and translational pediatric oncology research

Donald Durden

program and also head efforts to apply targeted therapeutics to other pediatric diseases at UC San Diego Medical Center and Rady Children’s Hospital-San Diego. His research focuses on angiogenesis and on major cellular and genetic control points that affect cancer development.

“We expect Dr. Durden to play a major role in our alliance with St. Jude’s Children’s Research Hospital, enhancing translational research and drug trials for difficult-to-treat cancers and taking advantage of the many on-going genomics efforts here at UC San Diego,” said Gabriel Haddad, MD, professor and chair of the UC San Diego Department of Pediatrics.

According to Haddad, Hagood and his team will work to meet the needs of patients at all levels, providing both patient care and education for future physicians and scientists and carrying out innovative science that will lead to new treatments.

“In Dr. Hagood, we are lucky to have a triple threat and a first rate physician-scientist,”

James Hagood

Haddad said, noting that Hagood is interested in both the clinical management of childhood chronic lung diseases and in “basic cellular and molecular investigations of chronic lung remodeling.” The National Institutes of Health and the American Lung Association have both funded Hagood’s research in lung fibrosis. “His interest in the molecular basis of pulmonary fibrosis dovetails very well with interests of others within our division, the department and institution.”  

Professional background

Durden was formerly the Aflac Endowed Chair and professor of Pediatrics at the Emory University School of Medicine and scientific director of Basic and Translational Research at Emory’s Aflac Center for Cancer and Blood Disorders.

He earned both a PhD in microbiology and immunology and his medical degree from the University of Miami School of Medicine. He served pediatrics residencies at Children’s Hospital Medical Center in Seattle and at St. Christopher Hospital for Children in Philadelphia, and was a postdoctoral fellow at Fred Hutchinson Cancer Research Center in Seattle and Children’s Hospital Medical Center.

Hagood was formerly director of the Pediatric Pulmonary Center at Children’s Hospital of Alabama. He was also associate professor in the Departments of Pediatrics, Cell Biology, and Biochemistry and Molecular Genetics at University of Alabama at Birmingham (UAB) School of Medicine. 

He earned his bachelor’s degree in English as well as his medical degree at the University of North Carolina at Chapel Hill. After an internship and residency at Vanderbilt University Medical Center, he completed his pediatric pulmonary fellowship at UAB.

# # #

 
Media Contacts:  Steve Benowitz, 619-543-6163, sbenowitz@ucsd.edu; Kim Edwards, 619-543-6163, kedwards@ucsd.edu




Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...


Share This Article



Follow Us: